Global Gene Therapy On Cardiovascular Disease Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Gene Therapy On Cardiovascular Disease market size was valued at US$ 13 million in 2023. With growing demand in downstream market, the Gene Therapy On Cardiovascular Disease is forecast to a readjusted size of US$ 1334.4 million by 2030 with a CAGR of 94.4% during review period.
The research report highlights the growth potential of the global Gene Therapy On Cardiovascular Disease market. Gene Therapy On Cardiovascular Disease are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Gene Therapy On Cardiovascular Disease. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Gene Therapy On Cardiovascular Disease market.
Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.
Although several conventional small-molecule treatments are available for common cardiovascular problems, gene therapy is a potential treatment option for acquired and inherited cardiovascular diseases that remain with unmet clinical needs.
Global key players of Gene Therapy On Cardiovascular Disease include Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals and Amgen, etc. Top three players occupy for a share about 76%. In terms of product, Non-Viral Gene Therapy is the largest segment, with a share over 100%. In terms of application, Vascular Disease is the largest market, with a share over 100%.
Key Features:
The report on Gene Therapy On Cardiovascular Disease market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Gene Therapy On Cardiovascular Disease market. It may include historical data, market segmentation by Type (e.g., Viral Gene Therapy, Non-Viral Gene Therapy), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Gene Therapy On Cardiovascular Disease market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Gene Therapy On Cardiovascular Disease market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Gene Therapy On Cardiovascular Disease industry. This include advancements in Gene Therapy On Cardiovascular Disease technology, Gene Therapy On Cardiovascular Disease new entrants, Gene Therapy On Cardiovascular Disease new investment, and other innovations that are shaping the future of Gene Therapy On Cardiovascular Disease.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Gene Therapy On Cardiovascular Disease market. It includes factors influencing customer ' purchasing decisions, preferences for Gene Therapy On Cardiovascular Disease product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Gene Therapy On Cardiovascular Disease market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Gene Therapy On Cardiovascular Disease market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Gene Therapy On Cardiovascular Disease market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Gene Therapy On Cardiovascular Disease industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Gene Therapy On Cardiovascular Disease market.
Market Segmentation:
Gene Therapy On Cardiovascular Disease market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Gene Therapy On Cardiovascular Disease market size was valued at US$ 13 million in 2023. With growing demand in downstream market, the Gene Therapy On Cardiovascular Disease is forecast to a readjusted size of US$ 1334.4 million by 2030 with a CAGR of 94.4% during review period.
The research report highlights the growth potential of the global Gene Therapy On Cardiovascular Disease market. Gene Therapy On Cardiovascular Disease are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Gene Therapy On Cardiovascular Disease. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Gene Therapy On Cardiovascular Disease market.
Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.
Although several conventional small-molecule treatments are available for common cardiovascular problems, gene therapy is a potential treatment option for acquired and inherited cardiovascular diseases that remain with unmet clinical needs.
Global key players of Gene Therapy On Cardiovascular Disease include Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals and Amgen, etc. Top three players occupy for a share about 76%. In terms of product, Non-Viral Gene Therapy is the largest segment, with a share over 100%. In terms of application, Vascular Disease is the largest market, with a share over 100%.
Key Features:
The report on Gene Therapy On Cardiovascular Disease market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Gene Therapy On Cardiovascular Disease market. It may include historical data, market segmentation by Type (e.g., Viral Gene Therapy, Non-Viral Gene Therapy), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Gene Therapy On Cardiovascular Disease market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Gene Therapy On Cardiovascular Disease market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Gene Therapy On Cardiovascular Disease industry. This include advancements in Gene Therapy On Cardiovascular Disease technology, Gene Therapy On Cardiovascular Disease new entrants, Gene Therapy On Cardiovascular Disease new investment, and other innovations that are shaping the future of Gene Therapy On Cardiovascular Disease.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Gene Therapy On Cardiovascular Disease market. It includes factors influencing customer ' purchasing decisions, preferences for Gene Therapy On Cardiovascular Disease product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Gene Therapy On Cardiovascular Disease market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Gene Therapy On Cardiovascular Disease market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Gene Therapy On Cardiovascular Disease market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Gene Therapy On Cardiovascular Disease industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Gene Therapy On Cardiovascular Disease market.
Market Segmentation:
Gene Therapy On Cardiovascular Disease market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Viral Gene Therapy
- Non-Viral Gene Therapy
- Heart Disease
- Vascular Disease
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Biogen
- Novartis
- Gilead Sciences
- Sarepta Therapeutics
- Alnylam Pharmaceuticals
- Amgen
- Spark Therapeutics
- Akcea Therapeutics
- bluebird bio
- Sunway Biotech
- SIBIONO
- AnGes
- Orchard Therapeutics
- Human Stem Cells Institute
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Gene Therapy On Cardiovascular Disease Market Size 2019-2030
2.1.2 Gene Therapy On Cardiovascular Disease Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Gene Therapy On Cardiovascular Disease Segment by Type
2.2.1 Viral Gene Therapy
2.2.2 Non-Viral Gene Therapy
2.3 Gene Therapy On Cardiovascular Disease Market Size by Type
2.3.1 Gene Therapy On Cardiovascular Disease Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Gene Therapy On Cardiovascular Disease Market Size Market Share by Type (2019-2024)
2.4 Gene Therapy On Cardiovascular Disease Segment by Application
2.4.1 Heart Disease
2.4.2 Vascular Disease
2.5 Gene Therapy On Cardiovascular Disease Market Size by Application
2.5.1 Gene Therapy On Cardiovascular Disease Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Gene Therapy On Cardiovascular Disease Market Size Market Share by Application (2019-2024)
3 GENE THERAPY ON CARDIOVASCULAR DISEASE MARKET SIZE BY PLAYER
3.1 Gene Therapy On Cardiovascular Disease Market Size Market Share by Players
3.1.1 Global Gene Therapy On Cardiovascular Disease Revenue by Players (2019-2024)
3.1.2 Global Gene Therapy On Cardiovascular Disease Revenue Market Share by Players (2019-2024)
3.2 Global Gene Therapy On Cardiovascular Disease Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 GENE THERAPY ON CARDIOVASCULAR DISEASE BY REGIONS
4.1 Gene Therapy On Cardiovascular Disease Market Size by Regions (2019-2024)
4.2 Americas Gene Therapy On Cardiovascular Disease Market Size Growth (2019-2024)
4.3 APAC Gene Therapy On Cardiovascular Disease Market Size Growth (2019-2024)
4.4 Europe Gene Therapy On Cardiovascular Disease Market Size Growth (2019-2024)
4.5 Middle East & Africa Gene Therapy On Cardiovascular Disease Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Gene Therapy On Cardiovascular Disease Market Size by Country (2019-2024)
5.2 Americas Gene Therapy On Cardiovascular Disease Market Size by Type (2019-2024)
5.3 Americas Gene Therapy On Cardiovascular Disease Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gene Therapy On Cardiovascular Disease Market Size by Region (2019-2024)
6.2 APAC Gene Therapy On Cardiovascular Disease Market Size by Type (2019-2024)
6.3 APAC Gene Therapy On Cardiovascular Disease Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Gene Therapy On Cardiovascular Disease by Country (2019-2024)
7.2 Europe Gene Therapy On Cardiovascular Disease Market Size by Type (2019-2024)
7.3 Europe Gene Therapy On Cardiovascular Disease Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Gene Therapy On Cardiovascular Disease by Region (2019-2024)
8.2 Middle East & Africa Gene Therapy On Cardiovascular Disease Market Size by Type (2019-2024)
8.3 Middle East & Africa Gene Therapy On Cardiovascular Disease Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL GENE THERAPY ON CARDIOVASCULAR DISEASE MARKET FORECAST
10.1 Global Gene Therapy On Cardiovascular Disease Forecast by Regions (2025-2030)
10.1.1 Global Gene Therapy On Cardiovascular Disease Forecast by Regions (2025-2030)
10.1.2 Americas Gene Therapy On Cardiovascular Disease Forecast
10.1.3 APAC Gene Therapy On Cardiovascular Disease Forecast
10.1.4 Europe Gene Therapy On Cardiovascular Disease Forecast
10.1.5 Middle East & Africa Gene Therapy On Cardiovascular Disease Forecast
10.2 Americas Gene Therapy On Cardiovascular Disease Forecast by Country (2025-2030)
10.2.1 United States Gene Therapy On Cardiovascular Disease Market Forecast
10.2.2 Canada Gene Therapy On Cardiovascular Disease Market Forecast
10.2.3 Mexico Gene Therapy On Cardiovascular Disease Market Forecast
10.2.4 Brazil Gene Therapy On Cardiovascular Disease Market Forecast
10.3 APAC Gene Therapy On Cardiovascular Disease Forecast by Region (2025-2030)
10.3.1 China Gene Therapy On Cardiovascular Disease Market Forecast
10.3.2 Japan Gene Therapy On Cardiovascular Disease Market Forecast
10.3.3 Korea Gene Therapy On Cardiovascular Disease Market Forecast
10.3.4 Southeast Asia Gene Therapy On Cardiovascular Disease Market Forecast
10.3.5 India Gene Therapy On Cardiovascular Disease Market Forecast
10.3.6 Australia Gene Therapy On Cardiovascular Disease Market Forecast
10.4 Europe Gene Therapy On Cardiovascular Disease Forecast by Country (2025-2030)
10.4.1 Germany Gene Therapy On Cardiovascular Disease Market Forecast
10.4.2 France Gene Therapy On Cardiovascular Disease Market Forecast
10.4.3 UK Gene Therapy On Cardiovascular Disease Market Forecast
10.4.4 Italy Gene Therapy On Cardiovascular Disease Market Forecast
10.4.5 Russia Gene Therapy On Cardiovascular Disease Market Forecast
10.5 Middle East & Africa Gene Therapy On Cardiovascular Disease Forecast by Region (2025-2030)
10.5.1 Egypt Gene Therapy On Cardiovascular Disease Market Forecast
10.5.2 South Africa Gene Therapy On Cardiovascular Disease Market Forecast
10.5.3 Israel Gene Therapy On Cardiovascular Disease Market Forecast
10.5.4 Turkey Gene Therapy On Cardiovascular Disease Market Forecast
10.5.5 GCC Countries Gene Therapy On Cardiovascular Disease Market Forecast
10.6 Global Gene Therapy On Cardiovascular Disease Forecast by Type (2025-2030)
10.7 Global Gene Therapy On Cardiovascular Disease Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Biogen
11.1.1 Biogen Company Information
11.1.2 Biogen Gene Therapy On Cardiovascular Disease Product Offered
11.1.3 Biogen Gene Therapy On Cardiovascular Disease Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Biogen Main Business Overview
11.1.5 Biogen Latest Developments
11.2 Novartis
11.2.1 Novartis Company Information
11.2.2 Novartis Gene Therapy On Cardiovascular Disease Product Offered
11.2.3 Novartis Gene Therapy On Cardiovascular Disease Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Novartis Main Business Overview
11.2.5 Novartis Latest Developments
11.3 Gilead Sciences
11.3.1 Gilead Sciences Company Information
11.3.2 Gilead Sciences Gene Therapy On Cardiovascular Disease Product Offered
11.3.3 Gilead Sciences Gene Therapy On Cardiovascular Disease Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Gilead Sciences Main Business Overview
11.3.5 Gilead Sciences Latest Developments
11.4 Sarepta Therapeutics
11.4.1 Sarepta Therapeutics Company Information
11.4.2 Sarepta Therapeutics Gene Therapy On Cardiovascular Disease Product Offered
11.4.3 Sarepta Therapeutics Gene Therapy On Cardiovascular Disease Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Sarepta Therapeutics Main Business Overview
11.4.5 Sarepta Therapeutics Latest Developments
11.5 Alnylam Pharmaceuticals
11.5.1 Alnylam Pharmaceuticals Company Information
11.5.2 Alnylam Pharmaceuticals Gene Therapy On Cardiovascular Disease Product Offered
11.5.3 Alnylam Pharmaceuticals Gene Therapy On Cardiovascular Disease Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Alnylam Pharmaceuticals Main Business Overview
11.5.5 Alnylam Pharmaceuticals Latest Developments
11.6 Amgen
11.6.1 Amgen Company Information
11.6.2 Amgen Gene Therapy On Cardiovascular Disease Product Offered
11.6.3 Amgen Gene Therapy On Cardiovascular Disease Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Amgen Main Business Overview
11.6.5 Amgen Latest Developments
11.7 Spark Therapeutics
11.7.1 Spark Therapeutics Company Information
11.7.2 Spark Therapeutics Gene Therapy On Cardiovascular Disease Product Offered
11.7.3 Spark Therapeutics Gene Therapy On Cardiovascular Disease Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Spark Therapeutics Main Business Overview
11.7.5 Spark Therapeutics Latest Developments
11.8 Akcea Therapeutics
11.8.1 Akcea Therapeutics Company Information
11.8.2 Akcea Therapeutics Gene Therapy On Cardiovascular Disease Product Offered
11.8.3 Akcea Therapeutics Gene Therapy On Cardiovascular Disease Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Akcea Therapeutics Main Business Overview
11.8.5 Akcea Therapeutics Latest Developments
11.9 bluebird bio
11.9.1 bluebird bio Company Information
11.9.2 bluebird bio Gene Therapy On Cardiovascular Disease Product Offered
11.9.3 bluebird bio Gene Therapy On Cardiovascular Disease Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 bluebird bio Main Business Overview
11.9.5 bluebird bio Latest Developments
11.10 Sunway Biotech
11.10.1 Sunway Biotech Company Information
11.10.2 Sunway Biotech Gene Therapy On Cardiovascular Disease Product Offered
11.10.3 Sunway Biotech Gene Therapy On Cardiovascular Disease Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Sunway Biotech Main Business Overview
11.10.5 Sunway Biotech Latest Developments
11.11 SIBIONO
11.11.1 SIBIONO Company Information
11.11.2 SIBIONO Gene Therapy On Cardiovascular Disease Product Offered
11.11.3 SIBIONO Gene Therapy On Cardiovascular Disease Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 SIBIONO Main Business Overview
11.11.5 SIBIONO Latest Developments
11.12 AnGes
11.12.1 AnGes Company Information
11.12.2 AnGes Gene Therapy On Cardiovascular Disease Product Offered
11.12.3 AnGes Gene Therapy On Cardiovascular Disease Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 AnGes Main Business Overview
11.12.5 AnGes Latest Developments
11.13 Orchard Therapeutics
11.13.1 Orchard Therapeutics Company Information
11.13.2 Orchard Therapeutics Gene Therapy On Cardiovascular Disease Product Offered
11.13.3 Orchard Therapeutics Gene Therapy On Cardiovascular Disease Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Orchard Therapeutics Main Business Overview
11.13.5 Orchard Therapeutics Latest Developments
11.14 Human Stem Cells Institute
11.14.1 Human Stem Cells Institute Company Information
11.14.2 Human Stem Cells Institute Gene Therapy On Cardiovascular Disease Product Offered
11.14.3 Human Stem Cells Institute Gene Therapy On Cardiovascular Disease Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Human Stem Cells Institute Main Business Overview
11.14.5 Human Stem Cells Institute Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Gene Therapy On Cardiovascular Disease Market Size 2019-2030
2.1.2 Gene Therapy On Cardiovascular Disease Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Gene Therapy On Cardiovascular Disease Segment by Type
2.2.1 Viral Gene Therapy
2.2.2 Non-Viral Gene Therapy
2.3 Gene Therapy On Cardiovascular Disease Market Size by Type
2.3.1 Gene Therapy On Cardiovascular Disease Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Gene Therapy On Cardiovascular Disease Market Size Market Share by Type (2019-2024)
2.4 Gene Therapy On Cardiovascular Disease Segment by Application
2.4.1 Heart Disease
2.4.2 Vascular Disease
2.5 Gene Therapy On Cardiovascular Disease Market Size by Application
2.5.1 Gene Therapy On Cardiovascular Disease Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Gene Therapy On Cardiovascular Disease Market Size Market Share by Application (2019-2024)
3 GENE THERAPY ON CARDIOVASCULAR DISEASE MARKET SIZE BY PLAYER
3.1 Gene Therapy On Cardiovascular Disease Market Size Market Share by Players
3.1.1 Global Gene Therapy On Cardiovascular Disease Revenue by Players (2019-2024)
3.1.2 Global Gene Therapy On Cardiovascular Disease Revenue Market Share by Players (2019-2024)
3.2 Global Gene Therapy On Cardiovascular Disease Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 GENE THERAPY ON CARDIOVASCULAR DISEASE BY REGIONS
4.1 Gene Therapy On Cardiovascular Disease Market Size by Regions (2019-2024)
4.2 Americas Gene Therapy On Cardiovascular Disease Market Size Growth (2019-2024)
4.3 APAC Gene Therapy On Cardiovascular Disease Market Size Growth (2019-2024)
4.4 Europe Gene Therapy On Cardiovascular Disease Market Size Growth (2019-2024)
4.5 Middle East & Africa Gene Therapy On Cardiovascular Disease Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Gene Therapy On Cardiovascular Disease Market Size by Country (2019-2024)
5.2 Americas Gene Therapy On Cardiovascular Disease Market Size by Type (2019-2024)
5.3 Americas Gene Therapy On Cardiovascular Disease Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gene Therapy On Cardiovascular Disease Market Size by Region (2019-2024)
6.2 APAC Gene Therapy On Cardiovascular Disease Market Size by Type (2019-2024)
6.3 APAC Gene Therapy On Cardiovascular Disease Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Gene Therapy On Cardiovascular Disease by Country (2019-2024)
7.2 Europe Gene Therapy On Cardiovascular Disease Market Size by Type (2019-2024)
7.3 Europe Gene Therapy On Cardiovascular Disease Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Gene Therapy On Cardiovascular Disease by Region (2019-2024)
8.2 Middle East & Africa Gene Therapy On Cardiovascular Disease Market Size by Type (2019-2024)
8.3 Middle East & Africa Gene Therapy On Cardiovascular Disease Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL GENE THERAPY ON CARDIOVASCULAR DISEASE MARKET FORECAST
10.1 Global Gene Therapy On Cardiovascular Disease Forecast by Regions (2025-2030)
10.1.1 Global Gene Therapy On Cardiovascular Disease Forecast by Regions (2025-2030)
10.1.2 Americas Gene Therapy On Cardiovascular Disease Forecast
10.1.3 APAC Gene Therapy On Cardiovascular Disease Forecast
10.1.4 Europe Gene Therapy On Cardiovascular Disease Forecast
10.1.5 Middle East & Africa Gene Therapy On Cardiovascular Disease Forecast
10.2 Americas Gene Therapy On Cardiovascular Disease Forecast by Country (2025-2030)
10.2.1 United States Gene Therapy On Cardiovascular Disease Market Forecast
10.2.2 Canada Gene Therapy On Cardiovascular Disease Market Forecast
10.2.3 Mexico Gene Therapy On Cardiovascular Disease Market Forecast
10.2.4 Brazil Gene Therapy On Cardiovascular Disease Market Forecast
10.3 APAC Gene Therapy On Cardiovascular Disease Forecast by Region (2025-2030)
10.3.1 China Gene Therapy On Cardiovascular Disease Market Forecast
10.3.2 Japan Gene Therapy On Cardiovascular Disease Market Forecast
10.3.3 Korea Gene Therapy On Cardiovascular Disease Market Forecast
10.3.4 Southeast Asia Gene Therapy On Cardiovascular Disease Market Forecast
10.3.5 India Gene Therapy On Cardiovascular Disease Market Forecast
10.3.6 Australia Gene Therapy On Cardiovascular Disease Market Forecast
10.4 Europe Gene Therapy On Cardiovascular Disease Forecast by Country (2025-2030)
10.4.1 Germany Gene Therapy On Cardiovascular Disease Market Forecast
10.4.2 France Gene Therapy On Cardiovascular Disease Market Forecast
10.4.3 UK Gene Therapy On Cardiovascular Disease Market Forecast
10.4.4 Italy Gene Therapy On Cardiovascular Disease Market Forecast
10.4.5 Russia Gene Therapy On Cardiovascular Disease Market Forecast
10.5 Middle East & Africa Gene Therapy On Cardiovascular Disease Forecast by Region (2025-2030)
10.5.1 Egypt Gene Therapy On Cardiovascular Disease Market Forecast
10.5.2 South Africa Gene Therapy On Cardiovascular Disease Market Forecast
10.5.3 Israel Gene Therapy On Cardiovascular Disease Market Forecast
10.5.4 Turkey Gene Therapy On Cardiovascular Disease Market Forecast
10.5.5 GCC Countries Gene Therapy On Cardiovascular Disease Market Forecast
10.6 Global Gene Therapy On Cardiovascular Disease Forecast by Type (2025-2030)
10.7 Global Gene Therapy On Cardiovascular Disease Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Biogen
11.1.1 Biogen Company Information
11.1.2 Biogen Gene Therapy On Cardiovascular Disease Product Offered
11.1.3 Biogen Gene Therapy On Cardiovascular Disease Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Biogen Main Business Overview
11.1.5 Biogen Latest Developments
11.2 Novartis
11.2.1 Novartis Company Information
11.2.2 Novartis Gene Therapy On Cardiovascular Disease Product Offered
11.2.3 Novartis Gene Therapy On Cardiovascular Disease Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Novartis Main Business Overview
11.2.5 Novartis Latest Developments
11.3 Gilead Sciences
11.3.1 Gilead Sciences Company Information
11.3.2 Gilead Sciences Gene Therapy On Cardiovascular Disease Product Offered
11.3.3 Gilead Sciences Gene Therapy On Cardiovascular Disease Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Gilead Sciences Main Business Overview
11.3.5 Gilead Sciences Latest Developments
11.4 Sarepta Therapeutics
11.4.1 Sarepta Therapeutics Company Information
11.4.2 Sarepta Therapeutics Gene Therapy On Cardiovascular Disease Product Offered
11.4.3 Sarepta Therapeutics Gene Therapy On Cardiovascular Disease Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Sarepta Therapeutics Main Business Overview
11.4.5 Sarepta Therapeutics Latest Developments
11.5 Alnylam Pharmaceuticals
11.5.1 Alnylam Pharmaceuticals Company Information
11.5.2 Alnylam Pharmaceuticals Gene Therapy On Cardiovascular Disease Product Offered
11.5.3 Alnylam Pharmaceuticals Gene Therapy On Cardiovascular Disease Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Alnylam Pharmaceuticals Main Business Overview
11.5.5 Alnylam Pharmaceuticals Latest Developments
11.6 Amgen
11.6.1 Amgen Company Information
11.6.2 Amgen Gene Therapy On Cardiovascular Disease Product Offered
11.6.3 Amgen Gene Therapy On Cardiovascular Disease Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Amgen Main Business Overview
11.6.5 Amgen Latest Developments
11.7 Spark Therapeutics
11.7.1 Spark Therapeutics Company Information
11.7.2 Spark Therapeutics Gene Therapy On Cardiovascular Disease Product Offered
11.7.3 Spark Therapeutics Gene Therapy On Cardiovascular Disease Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Spark Therapeutics Main Business Overview
11.7.5 Spark Therapeutics Latest Developments
11.8 Akcea Therapeutics
11.8.1 Akcea Therapeutics Company Information
11.8.2 Akcea Therapeutics Gene Therapy On Cardiovascular Disease Product Offered
11.8.3 Akcea Therapeutics Gene Therapy On Cardiovascular Disease Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Akcea Therapeutics Main Business Overview
11.8.5 Akcea Therapeutics Latest Developments
11.9 bluebird bio
11.9.1 bluebird bio Company Information
11.9.2 bluebird bio Gene Therapy On Cardiovascular Disease Product Offered
11.9.3 bluebird bio Gene Therapy On Cardiovascular Disease Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 bluebird bio Main Business Overview
11.9.5 bluebird bio Latest Developments
11.10 Sunway Biotech
11.10.1 Sunway Biotech Company Information
11.10.2 Sunway Biotech Gene Therapy On Cardiovascular Disease Product Offered
11.10.3 Sunway Biotech Gene Therapy On Cardiovascular Disease Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Sunway Biotech Main Business Overview
11.10.5 Sunway Biotech Latest Developments
11.11 SIBIONO
11.11.1 SIBIONO Company Information
11.11.2 SIBIONO Gene Therapy On Cardiovascular Disease Product Offered
11.11.3 SIBIONO Gene Therapy On Cardiovascular Disease Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 SIBIONO Main Business Overview
11.11.5 SIBIONO Latest Developments
11.12 AnGes
11.12.1 AnGes Company Information
11.12.2 AnGes Gene Therapy On Cardiovascular Disease Product Offered
11.12.3 AnGes Gene Therapy On Cardiovascular Disease Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 AnGes Main Business Overview
11.12.5 AnGes Latest Developments
11.13 Orchard Therapeutics
11.13.1 Orchard Therapeutics Company Information
11.13.2 Orchard Therapeutics Gene Therapy On Cardiovascular Disease Product Offered
11.13.3 Orchard Therapeutics Gene Therapy On Cardiovascular Disease Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Orchard Therapeutics Main Business Overview
11.13.5 Orchard Therapeutics Latest Developments
11.14 Human Stem Cells Institute
11.14.1 Human Stem Cells Institute Company Information
11.14.2 Human Stem Cells Institute Gene Therapy On Cardiovascular Disease Product Offered
11.14.3 Human Stem Cells Institute Gene Therapy On Cardiovascular Disease Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Human Stem Cells Institute Main Business Overview
11.14.5 Human Stem Cells Institute Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Gene Therapy On Cardiovascular Disease Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Viral Gene Therapy
Table 3. Major Players of Non-Viral Gene Therapy
Table 4. Gene Therapy On Cardiovascular Disease Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Gene Therapy On Cardiovascular Disease Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Gene Therapy On Cardiovascular Disease Market Size Market Share by Type (2019-2024)
Table 7. Gene Therapy On Cardiovascular Disease Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Gene Therapy On Cardiovascular Disease Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Gene Therapy On Cardiovascular Disease Market Size Market Share by Application (2019-2024)
Table 10. Global Gene Therapy On Cardiovascular Disease Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Gene Therapy On Cardiovascular Disease Revenue Market Share by Player (2019-2024)
Table 12. Gene Therapy On Cardiovascular Disease Key Players Head office and Products Offered
Table 13. Gene Therapy On Cardiovascular Disease Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Gene Therapy On Cardiovascular Disease Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Gene Therapy On Cardiovascular Disease Market Size Market Share by Regions (2019-2024)
Table 18. Global Gene Therapy On Cardiovascular Disease Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Gene Therapy On Cardiovascular Disease Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Gene Therapy On Cardiovascular Disease Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Gene Therapy On Cardiovascular Disease Market Size Market Share by Country (2019-2024)
Table 22. Americas Gene Therapy On Cardiovascular Disease Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Gene Therapy On Cardiovascular Disease Market Size Market Share by Type (2019-2024)
Table 24. Americas Gene Therapy On Cardiovascular Disease Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Gene Therapy On Cardiovascular Disease Market Size Market Share by Application (2019-2024)
Table 26. APAC Gene Therapy On Cardiovascular Disease Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Gene Therapy On Cardiovascular Disease Market Size Market Share by Region (2019-2024)
Table 28. APAC Gene Therapy On Cardiovascular Disease Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Gene Therapy On Cardiovascular Disease Market Size Market Share by Type (2019-2024)
Table 30. APAC Gene Therapy On Cardiovascular Disease Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Gene Therapy On Cardiovascular Disease Market Size Market Share by Application (2019-2024)
Table 32. Europe Gene Therapy On Cardiovascular Disease Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Gene Therapy On Cardiovascular Disease Market Size Market Share by Country (2019-2024)
Table 34. Europe Gene Therapy On Cardiovascular Disease Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Gene Therapy On Cardiovascular Disease Market Size Market Share by Type (2019-2024)
Table 36. Europe Gene Therapy On Cardiovascular Disease Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Gene Therapy On Cardiovascular Disease Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Gene Therapy On Cardiovascular Disease Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Gene Therapy On Cardiovascular Disease Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Gene Therapy On Cardiovascular Disease Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Gene Therapy On Cardiovascular Disease Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Gene Therapy On Cardiovascular Disease Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Gene Therapy On Cardiovascular Disease Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Gene Therapy On Cardiovascular Disease
Table 45. Key Market Challenges & Risks of Gene Therapy On Cardiovascular Disease
Table 46. Key Industry Trends of Gene Therapy On Cardiovascular Disease
Table 47. Global Gene Therapy On Cardiovascular Disease Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Gene Therapy On Cardiovascular Disease Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Gene Therapy On Cardiovascular Disease Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Gene Therapy On Cardiovascular Disease Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Biogen Details, Company Type, Gene Therapy On Cardiovascular Disease Area Served and Its Competitors
Table 52. Biogen Gene Therapy On Cardiovascular Disease Product Offered
Table 53. Biogen Gene Therapy On Cardiovascular Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Biogen Main Business
Table 55. Biogen Latest Developments
Table 56. Novartis Details, Company Type, Gene Therapy On Cardiovascular Disease Area Served and Its Competitors
Table 57. Novartis Gene Therapy On Cardiovascular Disease Product Offered
Table 58. Novartis Main Business
Table 59. Novartis Gene Therapy On Cardiovascular Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Novartis Latest Developments
Table 61. Gilead Sciences Details, Company Type, Gene Therapy On Cardiovascular Disease Area Served and Its Competitors
Table 62. Gilead Sciences Gene Therapy On Cardiovascular Disease Product Offered
Table 63. Gilead Sciences Main Business
Table 64. Gilead Sciences Gene Therapy On Cardiovascular Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Gilead Sciences Latest Developments
Table 66. Sarepta Therapeutics Details, Company Type, Gene Therapy On Cardiovascular Disease Area Served and Its Competitors
Table 67. Sarepta Therapeutics Gene Therapy On Cardiovascular Disease Product Offered
Table 68. Sarepta Therapeutics Main Business
Table 69. Sarepta Therapeutics Gene Therapy On Cardiovascular Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Sarepta Therapeutics Latest Developments
Table 71. Alnylam Pharmaceuticals Details, Company Type, Gene Therapy On Cardiovascular Disease Area Served and Its Competitors
Table 72. Alnylam Pharmaceuticals Gene Therapy On Cardiovascular Disease Product Offered
Table 73. Alnylam Pharmaceuticals Main Business
Table 74. Alnylam Pharmaceuticals Gene Therapy On Cardiovascular Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Alnylam Pharmaceuticals Latest Developments
Table 76. Amgen Details, Company Type, Gene Therapy On Cardiovascular Disease Area Served and Its Competitors
Table 77. Amgen Gene Therapy On Cardiovascular Disease Product Offered
Table 78. Amgen Main Business
Table 79. Amgen Gene Therapy On Cardiovascular Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Amgen Latest Developments
Table 81. Spark Therapeutics Details, Company Type, Gene Therapy On Cardiovascular Disease Area Served and Its Competitors
Table 82. Spark Therapeutics Gene Therapy On Cardiovascular Disease Product Offered
Table 83. Spark Therapeutics Main Business
Table 84. Spark Therapeutics Gene Therapy On Cardiovascular Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Spark Therapeutics Latest Developments
Table 86. Akcea Therapeutics Details, Company Type, Gene Therapy On Cardiovascular Disease Area Served and Its Competitors
Table 87. Akcea Therapeutics Gene Therapy On Cardiovascular Disease Product Offered
Table 88. Akcea Therapeutics Main Business
Table 89. Akcea Therapeutics Gene Therapy On Cardiovascular Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Akcea Therapeutics Latest Developments
Table 91. bluebird bio Details, Company Type, Gene Therapy On Cardiovascular Disease Area Served and Its Competitors
Table 92. bluebird bio Gene Therapy On Cardiovascular Disease Product Offered
Table 93. bluebird bio Main Business
Table 94. bluebird bio Gene Therapy On Cardiovascular Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. bluebird bio Latest Developments
Table 96. Sunway Biotech Details, Company Type, Gene Therapy On Cardiovascular Disease Area Served and Its Competitors
Table 97. Sunway Biotech Gene Therapy On Cardiovascular Disease Product Offered
Table 98. Sunway Biotech Main Business
Table 99. Sunway Biotech Gene Therapy On Cardiovascular Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. Sunway Biotech Latest Developments
Table 101. SIBIONO Details, Company Type, Gene Therapy On Cardiovascular Disease Area Served and Its Competitors
Table 102. SIBIONO Gene Therapy On Cardiovascular Disease Product Offered
Table 103. SIBIONO Gene Therapy On Cardiovascular Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. SIBIONO Main Business
Table 105. SIBIONO Latest Developments
Table 106. AnGes Details, Company Type, Gene Therapy On Cardiovascular Disease Area Served and Its Competitors
Table 107. AnGes Gene Therapy On Cardiovascular Disease Product Offered
Table 108. AnGes Main Business
Table 109. AnGes Gene Therapy On Cardiovascular Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 110. AnGes Latest Developments
Table 111. Orchard Therapeutics Details, Company Type, Gene Therapy On Cardiovascular Disease Area Served and Its Competitors
Table 112. Orchard Therapeutics Gene Therapy On Cardiovascular Disease Product Offered
Table 113. Orchard Therapeutics Main Business
Table 114. Orchard Therapeutics Gene Therapy On Cardiovascular Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 115. Orchard Therapeutics Latest Developments
Table 116. Human Stem Cells Institute Details, Company Type, Gene Therapy On Cardiovascular Disease Area Served and Its Competitors
Table 117. Human Stem Cells Institute Gene Therapy On Cardiovascular Disease Product Offered
Table 118. Human Stem Cells Institute Main Business
Table 119. Human Stem Cells Institute Gene Therapy On Cardiovascular Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 120. Human Stem Cells Institute Latest Developments
Table 1. Gene Therapy On Cardiovascular Disease Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Viral Gene Therapy
Table 3. Major Players of Non-Viral Gene Therapy
Table 4. Gene Therapy On Cardiovascular Disease Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Gene Therapy On Cardiovascular Disease Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Gene Therapy On Cardiovascular Disease Market Size Market Share by Type (2019-2024)
Table 7. Gene Therapy On Cardiovascular Disease Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Gene Therapy On Cardiovascular Disease Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Gene Therapy On Cardiovascular Disease Market Size Market Share by Application (2019-2024)
Table 10. Global Gene Therapy On Cardiovascular Disease Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Gene Therapy On Cardiovascular Disease Revenue Market Share by Player (2019-2024)
Table 12. Gene Therapy On Cardiovascular Disease Key Players Head office and Products Offered
Table 13. Gene Therapy On Cardiovascular Disease Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Gene Therapy On Cardiovascular Disease Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Gene Therapy On Cardiovascular Disease Market Size Market Share by Regions (2019-2024)
Table 18. Global Gene Therapy On Cardiovascular Disease Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Gene Therapy On Cardiovascular Disease Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Gene Therapy On Cardiovascular Disease Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Gene Therapy On Cardiovascular Disease Market Size Market Share by Country (2019-2024)
Table 22. Americas Gene Therapy On Cardiovascular Disease Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Gene Therapy On Cardiovascular Disease Market Size Market Share by Type (2019-2024)
Table 24. Americas Gene Therapy On Cardiovascular Disease Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Gene Therapy On Cardiovascular Disease Market Size Market Share by Application (2019-2024)
Table 26. APAC Gene Therapy On Cardiovascular Disease Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Gene Therapy On Cardiovascular Disease Market Size Market Share by Region (2019-2024)
Table 28. APAC Gene Therapy On Cardiovascular Disease Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Gene Therapy On Cardiovascular Disease Market Size Market Share by Type (2019-2024)
Table 30. APAC Gene Therapy On Cardiovascular Disease Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Gene Therapy On Cardiovascular Disease Market Size Market Share by Application (2019-2024)
Table 32. Europe Gene Therapy On Cardiovascular Disease Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Gene Therapy On Cardiovascular Disease Market Size Market Share by Country (2019-2024)
Table 34. Europe Gene Therapy On Cardiovascular Disease Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Gene Therapy On Cardiovascular Disease Market Size Market Share by Type (2019-2024)
Table 36. Europe Gene Therapy On Cardiovascular Disease Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Gene Therapy On Cardiovascular Disease Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Gene Therapy On Cardiovascular Disease Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Gene Therapy On Cardiovascular Disease Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Gene Therapy On Cardiovascular Disease Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Gene Therapy On Cardiovascular Disease Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Gene Therapy On Cardiovascular Disease Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Gene Therapy On Cardiovascular Disease Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Gene Therapy On Cardiovascular Disease
Table 45. Key Market Challenges & Risks of Gene Therapy On Cardiovascular Disease
Table 46. Key Industry Trends of Gene Therapy On Cardiovascular Disease
Table 47. Global Gene Therapy On Cardiovascular Disease Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Gene Therapy On Cardiovascular Disease Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Gene Therapy On Cardiovascular Disease Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Gene Therapy On Cardiovascular Disease Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Biogen Details, Company Type, Gene Therapy On Cardiovascular Disease Area Served and Its Competitors
Table 52. Biogen Gene Therapy On Cardiovascular Disease Product Offered
Table 53. Biogen Gene Therapy On Cardiovascular Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Biogen Main Business
Table 55. Biogen Latest Developments
Table 56. Novartis Details, Company Type, Gene Therapy On Cardiovascular Disease Area Served and Its Competitors
Table 57. Novartis Gene Therapy On Cardiovascular Disease Product Offered
Table 58. Novartis Main Business
Table 59. Novartis Gene Therapy On Cardiovascular Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Novartis Latest Developments
Table 61. Gilead Sciences Details, Company Type, Gene Therapy On Cardiovascular Disease Area Served and Its Competitors
Table 62. Gilead Sciences Gene Therapy On Cardiovascular Disease Product Offered
Table 63. Gilead Sciences Main Business
Table 64. Gilead Sciences Gene Therapy On Cardiovascular Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Gilead Sciences Latest Developments
Table 66. Sarepta Therapeutics Details, Company Type, Gene Therapy On Cardiovascular Disease Area Served and Its Competitors
Table 67. Sarepta Therapeutics Gene Therapy On Cardiovascular Disease Product Offered
Table 68. Sarepta Therapeutics Main Business
Table 69. Sarepta Therapeutics Gene Therapy On Cardiovascular Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Sarepta Therapeutics Latest Developments
Table 71. Alnylam Pharmaceuticals Details, Company Type, Gene Therapy On Cardiovascular Disease Area Served and Its Competitors
Table 72. Alnylam Pharmaceuticals Gene Therapy On Cardiovascular Disease Product Offered
Table 73. Alnylam Pharmaceuticals Main Business
Table 74. Alnylam Pharmaceuticals Gene Therapy On Cardiovascular Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Alnylam Pharmaceuticals Latest Developments
Table 76. Amgen Details, Company Type, Gene Therapy On Cardiovascular Disease Area Served and Its Competitors
Table 77. Amgen Gene Therapy On Cardiovascular Disease Product Offered
Table 78. Amgen Main Business
Table 79. Amgen Gene Therapy On Cardiovascular Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Amgen Latest Developments
Table 81. Spark Therapeutics Details, Company Type, Gene Therapy On Cardiovascular Disease Area Served and Its Competitors
Table 82. Spark Therapeutics Gene Therapy On Cardiovascular Disease Product Offered
Table 83. Spark Therapeutics Main Business
Table 84. Spark Therapeutics Gene Therapy On Cardiovascular Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Spark Therapeutics Latest Developments
Table 86. Akcea Therapeutics Details, Company Type, Gene Therapy On Cardiovascular Disease Area Served and Its Competitors
Table 87. Akcea Therapeutics Gene Therapy On Cardiovascular Disease Product Offered
Table 88. Akcea Therapeutics Main Business
Table 89. Akcea Therapeutics Gene Therapy On Cardiovascular Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Akcea Therapeutics Latest Developments
Table 91. bluebird bio Details, Company Type, Gene Therapy On Cardiovascular Disease Area Served and Its Competitors
Table 92. bluebird bio Gene Therapy On Cardiovascular Disease Product Offered
Table 93. bluebird bio Main Business
Table 94. bluebird bio Gene Therapy On Cardiovascular Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. bluebird bio Latest Developments
Table 96. Sunway Biotech Details, Company Type, Gene Therapy On Cardiovascular Disease Area Served and Its Competitors
Table 97. Sunway Biotech Gene Therapy On Cardiovascular Disease Product Offered
Table 98. Sunway Biotech Main Business
Table 99. Sunway Biotech Gene Therapy On Cardiovascular Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. Sunway Biotech Latest Developments
Table 101. SIBIONO Details, Company Type, Gene Therapy On Cardiovascular Disease Area Served and Its Competitors
Table 102. SIBIONO Gene Therapy On Cardiovascular Disease Product Offered
Table 103. SIBIONO Gene Therapy On Cardiovascular Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. SIBIONO Main Business
Table 105. SIBIONO Latest Developments
Table 106. AnGes Details, Company Type, Gene Therapy On Cardiovascular Disease Area Served and Its Competitors
Table 107. AnGes Gene Therapy On Cardiovascular Disease Product Offered
Table 108. AnGes Main Business
Table 109. AnGes Gene Therapy On Cardiovascular Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 110. AnGes Latest Developments
Table 111. Orchard Therapeutics Details, Company Type, Gene Therapy On Cardiovascular Disease Area Served and Its Competitors
Table 112. Orchard Therapeutics Gene Therapy On Cardiovascular Disease Product Offered
Table 113. Orchard Therapeutics Main Business
Table 114. Orchard Therapeutics Gene Therapy On Cardiovascular Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 115. Orchard Therapeutics Latest Developments
Table 116. Human Stem Cells Institute Details, Company Type, Gene Therapy On Cardiovascular Disease Area Served and Its Competitors
Table 117. Human Stem Cells Institute Gene Therapy On Cardiovascular Disease Product Offered
Table 118. Human Stem Cells Institute Main Business
Table 119. Human Stem Cells Institute Gene Therapy On Cardiovascular Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 120. Human Stem Cells Institute Latest Developments
LIST OF FIGURES
Figure 1. Gene Therapy On Cardiovascular Disease Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Gene Therapy On Cardiovascular Disease Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Gene Therapy On Cardiovascular Disease Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Gene Therapy On Cardiovascular Disease Sales Market Share by Country/Region (2023)
Figure 8. Gene Therapy On Cardiovascular Disease Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Gene Therapy On Cardiovascular Disease Market Size Market Share by Type in 2023
Figure 10. Gene Therapy On Cardiovascular Disease in Heart Disease
Figure 11. Global Gene Therapy On Cardiovascular Disease Market: Heart Disease (2019-2024) & ($ Millions)
Figure 12. Gene Therapy On Cardiovascular Disease in Vascular Disease
Figure 13. Global Gene Therapy On Cardiovascular Disease Market: Vascular Disease (2019-2024) & ($ Millions)
Figure 14. Global Gene Therapy On Cardiovascular Disease Market Size Market Share by Application in 2023
Figure 15. Global Gene Therapy On Cardiovascular Disease Revenue Market Share by Player in 2023
Figure 16. Global Gene Therapy On Cardiovascular Disease Market Size Market Share by Regions (2019-2024)
Figure 17. Americas Gene Therapy On Cardiovascular Disease Market Size 2019-2024 ($ Millions)
Figure 18. APAC Gene Therapy On Cardiovascular Disease Market Size 2019-2024 ($ Millions)
Figure 19. Europe Gene Therapy On Cardiovascular Disease Market Size 2019-2024 ($ Millions)
Figure 20. Middle East & Africa Gene Therapy On Cardiovascular Disease Market Size 2019-2024 ($ Millions)
Figure 21. Americas Gene Therapy On Cardiovascular Disease Value Market Share by Country in 2023
Figure 22. United States Gene Therapy On Cardiovascular Disease Market Size Growth 2019-2024 ($ Millions)
Figure 23. Canada Gene Therapy On Cardiovascular Disease Market Size Growth 2019-2024 ($ Millions)
Figure 24. Mexico Gene Therapy On Cardiovascular Disease Market Size Growth 2019-2024 ($ Millions)
Figure 25. Brazil Gene Therapy On Cardiovascular Disease Market Size Growth 2019-2024 ($ Millions)
Figure 26. APAC Gene Therapy On Cardiovascular Disease Market Size Market Share by Region in 2023
Figure 27. APAC Gene Therapy On Cardiovascular Disease Market Size Market Share by Type in 2023
Figure 28. APAC Gene Therapy On Cardiovascular Disease Market Size Market Share by Application in 2023
Figure 29. China Gene Therapy On Cardiovascular Disease Market Size Growth 2019-2024 ($ Millions)
Figure 30. Japan Gene Therapy On Cardiovascular Disease Market Size Growth 2019-2024 ($ Millions)
Figure 31. Korea Gene Therapy On Cardiovascular Disease Market Size Growth 2019-2024 ($ Millions)
Figure 32. Southeast Asia Gene Therapy On Cardiovascular Disease Market Size Growth 2019-2024 ($ Millions)
Figure 33. India Gene Therapy On Cardiovascular Disease Market Size Growth 2019-2024 ($ Millions)
Figure 34. Australia Gene Therapy On Cardiovascular Disease Market Size Growth 2019-2024 ($ Millions)
Figure 35. Europe Gene Therapy On Cardiovascular Disease Market Size Market Share by Country in 2023
Figure 36. Europe Gene Therapy On Cardiovascular Disease Market Size Market Share by Type (2019-2024)
Figure 37. Europe Gene Therapy On Cardiovascular Disease Market Size Market Share by Application (2019-2024)
Figure 38. Germany Gene Therapy On Cardiovascular Disease Market Size Growth 2019-2024 ($ Millions)
Figure 39. France Gene Therapy On Cardiovascular Disease Market Size Growth 2019-2024 ($ Millions)
Figure 40. UK Gene Therapy On Cardiovascular Disease Market Size Growth 2019-2024 ($ Millions)
Figure 41. Italy Gene Therapy On Cardiovascular Disease Market Size Growth 2019-2024 ($ Millions)
Figure 42. Russia Gene Therapy On Cardiovascular Disease Market Size Growth 2019-2024 ($ Millions)
Figure 43. Middle East & Africa Gene Therapy On Cardiovascular Disease Market Size Market Share by Region (2019-2024)
Figure 44. Middle East & Africa Gene Therapy On Cardiovascular Disease Market Size Market Share by Type (2019-2024)
Figure 45. Middle East & Africa Gene Therapy On Cardiovascular Disease Market Size Market Share by Application (2019-2024)
Figure 46. Egypt Gene Therapy On Cardiovascular Disease Market Size Growth 2019-2024 ($ Millions)
Figure 47. South Africa Gene Therapy On Cardiovascular Disease Market Size Growth 2019-2024 ($ Millions)
Figure 48. Israel Gene Therapy On Cardiovascular Disease Market Size Growth 2019-2024 ($ Millions)
Figure 49. Turkey Gene Therapy On Cardiovascular Disease Market Size Growth 2019-2024 ($ Millions)
Figure 50. GCC Country Gene Therapy On Cardiovascular Disease Market Size Growth 2019-2024 ($ Millions)
Figure 51. Americas Gene Therapy On Cardiovascular Disease Market Size 2025-2030 ($ Millions)
Figure 52. APAC Gene Therapy On Cardiovascular Disease Market Size 2025-2030 ($ Millions)
Figure 53. Europe Gene Therapy On Cardiovascular Disease Market Size 2025-2030 ($ Millions)
Figure 54. Middle East & Africa Gene Therapy On Cardiovascular Disease Market Size 2025-2030 ($ Millions)
Figure 55. United States Gene Therapy On Cardiovascular Disease Market Size 2025-2030 ($ Millions)
Figure 56. Canada Gene Therapy On Cardiovascular Disease Market Size 2025-2030 ($ Millions)
Figure 57. Mexico Gene Therapy On Cardiovascular Disease Market Size 2025-2030 ($ Millions)
Figure 58. Brazil Gene Therapy On Cardiovascular Disease Market Size 2025-2030 ($ Millions)
Figure 59. China Gene Therapy On Cardiovascular Disease Market Size 2025-2030 ($ Millions)
Figure 60. Japan Gene Therapy On Cardiovascular Disease Market Size 2025-2030 ($ Millions)
Figure 61. Korea Gene Therapy On Cardiovascular Disease Market Size 2025-2030 ($ Millions)
Figure 62. Southeast Asia Gene Therapy On Cardiovascular Disease Market Size 2025-2030 ($ Millions)
Figure 63. India Gene Therapy On Cardiovascular Disease Market Size 2025-2030 ($ Millions)
Figure 64. Australia Gene Therapy On Cardiovascular Disease Market Size 2025-2030 ($ Millions)
Figure 65. Germany Gene Therapy On Cardiovascular Disease Market Size 2025-2030 ($ Millions)
Figure 66. France Gene Therapy On Cardiovascular Disease Market Size 2025-2030 ($ Millions)
Figure 67. UK Gene Therapy On Cardiovascular Disease Market Size 2025-2030 ($ Millions)
Figure 68. Italy Gene Therapy On Cardiovascular Disease Market Size 2025-2030 ($ Millions)
Figure 69. Russia Gene Therapy On Cardiovascular Disease Market Size 2025-2030 ($ Millions)
Figure 70. Spain Gene Therapy On Cardiovascular Disease Market Size 2025-2030 ($ Millions)
Figure 71. Egypt Gene Therapy On Cardiovascular Disease Market Size 2025-2030 ($ Millions)
Figure 72. South Africa Gene Therapy On Cardiovascular Disease Market Size 2025-2030 ($ Millions)
Figure 73. Israel Gene Therapy On Cardiovascular Disease Market Size 2025-2030 ($ Millions)
Figure 74. Turkey Gene Therapy On Cardiovascular Disease Market Size 2025-2030 ($ Millions)
Figure 75. GCC Countries Gene Therapy On Cardiovascular Disease Market Size 2025-2030 ($ Millions)
Figure 76. Global Gene Therapy On Cardiovascular Disease Market Size Market Share Forecast by Type (2025-2030)
Figure 77. Global Gene Therapy On Cardiovascular Disease Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Gene Therapy On Cardiovascular Disease Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Gene Therapy On Cardiovascular Disease Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Gene Therapy On Cardiovascular Disease Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Gene Therapy On Cardiovascular Disease Sales Market Share by Country/Region (2023)
Figure 8. Gene Therapy On Cardiovascular Disease Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Gene Therapy On Cardiovascular Disease Market Size Market Share by Type in 2023
Figure 10. Gene Therapy On Cardiovascular Disease in Heart Disease
Figure 11. Global Gene Therapy On Cardiovascular Disease Market: Heart Disease (2019-2024) & ($ Millions)
Figure 12. Gene Therapy On Cardiovascular Disease in Vascular Disease
Figure 13. Global Gene Therapy On Cardiovascular Disease Market: Vascular Disease (2019-2024) & ($ Millions)
Figure 14. Global Gene Therapy On Cardiovascular Disease Market Size Market Share by Application in 2023
Figure 15. Global Gene Therapy On Cardiovascular Disease Revenue Market Share by Player in 2023
Figure 16. Global Gene Therapy On Cardiovascular Disease Market Size Market Share by Regions (2019-2024)
Figure 17. Americas Gene Therapy On Cardiovascular Disease Market Size 2019-2024 ($ Millions)
Figure 18. APAC Gene Therapy On Cardiovascular Disease Market Size 2019-2024 ($ Millions)
Figure 19. Europe Gene Therapy On Cardiovascular Disease Market Size 2019-2024 ($ Millions)
Figure 20. Middle East & Africa Gene Therapy On Cardiovascular Disease Market Size 2019-2024 ($ Millions)
Figure 21. Americas Gene Therapy On Cardiovascular Disease Value Market Share by Country in 2023
Figure 22. United States Gene Therapy On Cardiovascular Disease Market Size Growth 2019-2024 ($ Millions)
Figure 23. Canada Gene Therapy On Cardiovascular Disease Market Size Growth 2019-2024 ($ Millions)
Figure 24. Mexico Gene Therapy On Cardiovascular Disease Market Size Growth 2019-2024 ($ Millions)
Figure 25. Brazil Gene Therapy On Cardiovascular Disease Market Size Growth 2019-2024 ($ Millions)
Figure 26. APAC Gene Therapy On Cardiovascular Disease Market Size Market Share by Region in 2023
Figure 27. APAC Gene Therapy On Cardiovascular Disease Market Size Market Share by Type in 2023
Figure 28. APAC Gene Therapy On Cardiovascular Disease Market Size Market Share by Application in 2023
Figure 29. China Gene Therapy On Cardiovascular Disease Market Size Growth 2019-2024 ($ Millions)
Figure 30. Japan Gene Therapy On Cardiovascular Disease Market Size Growth 2019-2024 ($ Millions)
Figure 31. Korea Gene Therapy On Cardiovascular Disease Market Size Growth 2019-2024 ($ Millions)
Figure 32. Southeast Asia Gene Therapy On Cardiovascular Disease Market Size Growth 2019-2024 ($ Millions)
Figure 33. India Gene Therapy On Cardiovascular Disease Market Size Growth 2019-2024 ($ Millions)
Figure 34. Australia Gene Therapy On Cardiovascular Disease Market Size Growth 2019-2024 ($ Millions)
Figure 35. Europe Gene Therapy On Cardiovascular Disease Market Size Market Share by Country in 2023
Figure 36. Europe Gene Therapy On Cardiovascular Disease Market Size Market Share by Type (2019-2024)
Figure 37. Europe Gene Therapy On Cardiovascular Disease Market Size Market Share by Application (2019-2024)
Figure 38. Germany Gene Therapy On Cardiovascular Disease Market Size Growth 2019-2024 ($ Millions)
Figure 39. France Gene Therapy On Cardiovascular Disease Market Size Growth 2019-2024 ($ Millions)
Figure 40. UK Gene Therapy On Cardiovascular Disease Market Size Growth 2019-2024 ($ Millions)
Figure 41. Italy Gene Therapy On Cardiovascular Disease Market Size Growth 2019-2024 ($ Millions)
Figure 42. Russia Gene Therapy On Cardiovascular Disease Market Size Growth 2019-2024 ($ Millions)
Figure 43. Middle East & Africa Gene Therapy On Cardiovascular Disease Market Size Market Share by Region (2019-2024)
Figure 44. Middle East & Africa Gene Therapy On Cardiovascular Disease Market Size Market Share by Type (2019-2024)
Figure 45. Middle East & Africa Gene Therapy On Cardiovascular Disease Market Size Market Share by Application (2019-2024)
Figure 46. Egypt Gene Therapy On Cardiovascular Disease Market Size Growth 2019-2024 ($ Millions)
Figure 47. South Africa Gene Therapy On Cardiovascular Disease Market Size Growth 2019-2024 ($ Millions)
Figure 48. Israel Gene Therapy On Cardiovascular Disease Market Size Growth 2019-2024 ($ Millions)
Figure 49. Turkey Gene Therapy On Cardiovascular Disease Market Size Growth 2019-2024 ($ Millions)
Figure 50. GCC Country Gene Therapy On Cardiovascular Disease Market Size Growth 2019-2024 ($ Millions)
Figure 51. Americas Gene Therapy On Cardiovascular Disease Market Size 2025-2030 ($ Millions)
Figure 52. APAC Gene Therapy On Cardiovascular Disease Market Size 2025-2030 ($ Millions)
Figure 53. Europe Gene Therapy On Cardiovascular Disease Market Size 2025-2030 ($ Millions)
Figure 54. Middle East & Africa Gene Therapy On Cardiovascular Disease Market Size 2025-2030 ($ Millions)
Figure 55. United States Gene Therapy On Cardiovascular Disease Market Size 2025-2030 ($ Millions)
Figure 56. Canada Gene Therapy On Cardiovascular Disease Market Size 2025-2030 ($ Millions)
Figure 57. Mexico Gene Therapy On Cardiovascular Disease Market Size 2025-2030 ($ Millions)
Figure 58. Brazil Gene Therapy On Cardiovascular Disease Market Size 2025-2030 ($ Millions)
Figure 59. China Gene Therapy On Cardiovascular Disease Market Size 2025-2030 ($ Millions)
Figure 60. Japan Gene Therapy On Cardiovascular Disease Market Size 2025-2030 ($ Millions)
Figure 61. Korea Gene Therapy On Cardiovascular Disease Market Size 2025-2030 ($ Millions)
Figure 62. Southeast Asia Gene Therapy On Cardiovascular Disease Market Size 2025-2030 ($ Millions)
Figure 63. India Gene Therapy On Cardiovascular Disease Market Size 2025-2030 ($ Millions)
Figure 64. Australia Gene Therapy On Cardiovascular Disease Market Size 2025-2030 ($ Millions)
Figure 65. Germany Gene Therapy On Cardiovascular Disease Market Size 2025-2030 ($ Millions)
Figure 66. France Gene Therapy On Cardiovascular Disease Market Size 2025-2030 ($ Millions)
Figure 67. UK Gene Therapy On Cardiovascular Disease Market Size 2025-2030 ($ Millions)
Figure 68. Italy Gene Therapy On Cardiovascular Disease Market Size 2025-2030 ($ Millions)
Figure 69. Russia Gene Therapy On Cardiovascular Disease Market Size 2025-2030 ($ Millions)
Figure 70. Spain Gene Therapy On Cardiovascular Disease Market Size 2025-2030 ($ Millions)
Figure 71. Egypt Gene Therapy On Cardiovascular Disease Market Size 2025-2030 ($ Millions)
Figure 72. South Africa Gene Therapy On Cardiovascular Disease Market Size 2025-2030 ($ Millions)
Figure 73. Israel Gene Therapy On Cardiovascular Disease Market Size 2025-2030 ($ Millions)
Figure 74. Turkey Gene Therapy On Cardiovascular Disease Market Size 2025-2030 ($ Millions)
Figure 75. GCC Countries Gene Therapy On Cardiovascular Disease Market Size 2025-2030 ($ Millions)
Figure 76. Global Gene Therapy On Cardiovascular Disease Market Size Market Share Forecast by Type (2025-2030)
Figure 77. Global Gene Therapy On Cardiovascular Disease Market Size Market Share Forecast by Application (2025-2030)
